الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 107 |  |  |
| | | from | 107 | | |
Abstract
A prospective study was conducted on 60 diabetic children and 30 healthy children as a control group in Minia university hospital from July 2014 to November 2015.children with type one diabetes follow up in diabetes clinic in our hospital were consectutively enrolled into the study.They presented initially and received therapy in our hospital and had not been treated for diabetes elsewhere.
Our results showed that:
There were non-significant differences between patients and control groups regarding age, residence and family history of DM
There were non-significant differences between patients and control groups regarding weight, height, body mass index and ultrasound liver size.
There were statistically significant differences between patients and control groups regarding blood sugar and HbA1c and non significant differences between patients and control groups regarding other biochemical profile parameters.
There were - non significant difference between sex and both type of diet in patients group and type of liver changes (hepatomegaly, hyperechogenic or normal liver).
There were ststistically significant differences between HbA1c and insulin dose and hyperechogenic liver in type 1 diabetes and non significant differences regarding age, weight, height, body mass index and blood sugar.
There were statistically significant differences between low density lipoprotein, triglycerides, cholesterol, U/S liver size and hyperechogenic liver in type 1diabetes, and non significant differences regarding high density lipoprotein, alanine aminotransferase and aspartate aminotransferase.
There was statistically significant difference between ultrasound findings of the liver and type of diet in patients group.
There was statistically a significant difference between hyperechogenic liver and type of diet in patients group.
There was statistically a significant difference between before and after 3 months follow up regarding glycated hemoglobin and U/S liver size at onset of study and after 3 months follow up.